US health utility in advanced non-small cell lung cancer (NSCLC) patients harboring MET exon 14 (METex14) skipping mutations treated with tepotinib Meeting Abstract


Authors: Paik, P. K.; Yang, M.; Knowles, E.; Hatswell, A.; Vioix, H.; Liu, F. X.
Abstract Title: US health utility in advanced non-small cell lung cancer (NSCLC) patients harboring MET exon 14 (METex14) skipping mutations treated with tepotinib
Meeting Title: 2021 ASCO Quality Care Symposium
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 28 Suppl.
Meeting Dates: 2021 Sep 24-25
Meeting Location: Boston, MA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-10-01
Language: English
ACCESSION: WOS:000707130200315
DOI: 10.1200/JCO.2020.39.28_suppl.319
PROVIDER: wos
Notes: Meeting Abstract: 319 -- Virtual event option was available online -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik